Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
DAVID MARCUS: In Harlem, excitement for Mamdani and...
Trump learns how to fend off the Chinese...
Trump pressed on whether he ordered DOJ to...
Senate returns to work as government shutdown nears...
Energy secretary reveals how US nuclear tests will...
Sarama Files Memorial in US$242M Damages Claim Against...
RUA GOLD Engages ICP Securities Inc. for Automated...
Spartan Metals Identifies High-Grade Silver-Rich CRD Target on...
Locksley Receives Up to US$191 Million Potential Support...
Anteros Metals Inc. Announces Closing of First Tranche...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

by admin August 17, 2024
August 17, 2024
Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

A bipartisan group of lawmakers sent Meta CEO Mark Zuckerberg a letter on Thursday expressing concern that the company is failing to prevent illicit drug advertisements from running on its platform.

The House members cited recent reports from The Wall Street Journal and nonprofit Tech Transparency Project, which uncovered a flood of ads on Facebook and Instagram that pointed users to third-party services where they could purchase prescription pills, cocaine and other recreational drugs.

“On March 16, 2024, the Wall Street Journal reported that U.S. federal prosecutors have been investigating Meta for facilitating the sale of illicit drugs,” the lawmakers wrote. “Instead of quickly addressing the issue and fully removing the illicit content, on July 31, 2024, the Wall Street Journal again reported that Meta was ‘“running ads on Facebook and Instagram that steer users to online marketplaces for illegal drugs.’”

Most troubling, they wrote, is that Meta continues to run ads despite the company facing an investigation by U.S. federal prosecutors “for facilitating the sale of illicit drugs.”

The letter’s 19 authors include Reps. Tim Walberg (R-Mich.), Gus Bilirakis (R-Fla.), Kathy Castor (D-Fla.) and Lori Trahan (D-Mass.). They noted that the illicit drug ads were “approved and monetized by Meta” and that they were not hidden on the dark web or private social media pages. Media outlets and researchers could easily find the ads, which contained “contained blatant references to illegal drugs,” while Meta’s internal processes apparently missed them.

“Time and time again we have heard from Meta that users come to your platforms because they like the personalization and experiences you provide, and you use sensitive personal information to direct such personalization through content and advertisements,” the lawmakers wrote. “We in Congress, on multiple occasions, have worked to establish data privacy and security protections for Americans but have, in each instance, been met with friction and opposition from Meta with claims that we would drastically disrupt this personalization you are providing.”

They sent Zuckerberg a list of 15 questions intended to uncover more details about how Meta is addressing the problem, and asked him to respond by Sept. 6.

Meta confirmed receipt of the letter and said it plans to respond. The company shared with CNBC the same statement it gave the Journal for its initial story.

“Drug dealers are criminals who work across platforms and communities, which is why we work with law enforcement to help combat this activity. Our systems are designed to proactively detect and enforce against violating content, and we reject hundreds of thousands of ads for violating our drug policies. We continue to invest resources and further improve our enforcement on this kind of content. Our hearts go out to those suffering from the tragic consequences of this epidemic — it requires all of us to work together to stop it.”

This post appeared first on NBC NEWS

previous post
‘Election interference’: Trump lawyers call for delayed sentencing in Bragg case
next post
True North Copper

You may also like

CrowdStrike losses may be biggest test yet of...

July 25, 2024

Trump commutes sentence of Ozy Media founder Carlos...

March 30, 2025

Macy’s confirms rogue employee hid $151 million in...

December 12, 2024

Walmart is using its own fintech firm to...

June 11, 2025

Ad revenue should stabilize for media companies in...

December 31, 2024

Mortgage refinance demand jumps to a 2-year high,...

July 19, 2024

Google says U.S. is facing a power capacity...

February 13, 2025

Giorgio Armani group names longtime executive Giuseppe Marsocci...

October 18, 2025

Trump Media stock drops 5% after quarterly loss...

August 14, 2024

Shares of generator maker soar, insurance stocks fall...

October 10, 2024

Recent Posts

  • DAVID MARCUS: In Harlem, excitement for Mamdani and a warning for Cuomo
  • Trump learns how to fend off the Chinese threat like he is reading Sun Tzu
  • Trump pressed on whether he ordered DOJ to target James Comey, John Bolton, Letitia James
  • Senate returns to work as government shutdown nears longest in US history over Obamacare fight
  • Energy secretary reveals how US nuclear tests will work

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (946)
    • Investing (3,338)
    • Politics (4,085)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.